Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes
暂无分享,去创建一个
Malachi Griffith | Kilannin Krysiak | Erica K. Barnell | Katie M. Campbell | Adam Waalkes | Kelsi Penewit | Ravindra Uppaluri | Ramaswamy Govindan | Obi L Griffith | Kelsy C. Cotto | Erica K Barnell | Matt C Mosior | Kelsy C Cotto | Arpad M Danos | Lana M Sheta | Katie M Campbell | Damian Rieke | Nicholas C Spies | Zachary L Skidmore | Colin C Pritchard | Todd A Fehniger | Stephen J Salipante | Lana M. Sheta | Zachary L. Skidmore | O. Griffith | M. Griffith | N. Spies | R. Govindan | Kilannin Krysiak | Arpad M. Danos | D. Rieke | Z. Skidmore | C. Pritchard | S. Salipante | Matthew Mosior | T. Fehniger | R. Uppaluri | A. Waalkes | K. Penewit
[1] A. Gonzalez-Perez,et al. Rational design of cancer gene panels with OncoPaD , 2016, Genome Medicine.
[2] E. Mardis. The $1,000 genome, the $100,000 analysis? , 2010, Genome Medicine.
[3] Marc S. Williams,et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.
[4] Michael P. Schroeder,et al. Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations , 2017, Genome Medicine.
[5] Anuradha Lakshminarayana,et al. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies , 2016, Human Genomics.
[6] Donavan T. Cheng,et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.
[7] Obi L. Griffith,et al. Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples , 2018, Genetics in Medicine.
[8] F. Collins,et al. A new initiative on precision medicine. , 2015, The New England journal of medicine.
[9] Moriah H Nissan,et al. OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.
[10] Benjamin M. Good,et al. Organizing knowledge to enable personalization of medicine in cancer , 2014, Genome Biology.
[11] Emily H Turner,et al. Actionable, pathogenic incidental findings in 1,000 participants' exomes. , 2013, American journal of human genetics.
[12] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[13] Mingming Jia,et al. COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..
[14] Alex H. Wagner,et al. Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer , 2018, Nature Communications.
[15] Akash Kumar,et al. MIPgen: optimized modeling and design of molecular inversion probes for targeted resequencing , 2014, Bioinform..
[16] Subha Madhavan,et al. A harmonized meta-knowledgebase of clinical interpretations of cancer genomic variants , 2018, bioRxiv.
[17] Marcin Imielinski,et al. The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations , 2016, J. Am. Medical Informatics Assoc..
[18] Deanna M. Church,et al. ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..
[19] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[20] B. Wood,et al. Ultrasensitive detection of acute myeloid leukemia minimal residual disease using single molecule molecular inversion probes , 2017, Haematologica.
[21] Obi L. Griffith,et al. Genome Modeling System: A Knowledge Management Platform for Genomics , 2015, PLoS Comput. Biol..
[22] L. Harris,et al. The HER2 extracellular domain as a prognostic and predictive factor in breast cancer. , 2002, Clinical breast cancer.
[23] Joshua F. McMichael,et al. Optimizing cancer genome sequencing and analysis. , 2015, Cell systems.
[24] M. Ahn,et al. Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases , 2016, Journal of pathology and translational medicine.
[25] Jane C Weeks,et al. Physicians' attitudes about multiplex tumor genomic testing. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] Steven J. M. Jones,et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer , 2017, Nature Genetics.
[27] H. Chaturvedi,et al. FoundationOne as a relevant tool for comprehensive genomic profiling and assessment of tumor mutation burden in the era of precision oncology in India. , 2017 .